Chairman and CEO of Abbott Laboratories (NYSE:ABT), recently sold a significant portion of his holdings in the company. According to a Form 4 filing with the Securities and Exchange Commission, Ford ...

The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...

The stock's fall snapped a three-day winning streak.

StockNews.com upgraded shares of Abbott Laboratories (NYSE:ABT – Free Report) from a buy rating to a strong-buy rating in a ...

Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements. Abbott is expected to post earnings of $1.07 ...

Abbott Laboratories (NYSE:ABT – Get Free Report) had its price target increased by Wells Fargo & Company from $133.00 to $136 ...

Financial analysis of Abbott Laboratories Q4 2024 results and 2025 outlook, with a 'Buy' rating due to revenue growth and EPS ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the consensus estimates of $11.01 billion and ...